Prevention of cardiovascular disease by the early identification of erectile dysfunction

被引:51
|
作者
Jackson, G. [1 ]
机构
[1] Guys & St Thomas NHS Fdn Trust, Ctr Cardiothorac, London, England
关键词
D O I
10.1038/ijir.2008.47
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Both erectile dysfunction (ED) and vascular disease share the same risk factors and the two conditions often coexist, with endothelial dysfunction being the common underlying pathophysiology. Up to two-thirds of all patients with clinically evident coronary artery disease (CAD) have ED. Because of their smaller size, the same degree of lipid plaque burden has a greater effect on the penile arteries compared with the coronary arteries. As a result, the clinical consequences of penile vascular disease (ED) frequently manifest 2-3 years before the consequences of coronary atherosclerosis. This phenomenon has led to the widespread view that ED is a silent marker of vascular disease, particularly CAD, in otherwise asymptomatic men. The Second Princeton Consensus Guidelines reflect this by stating that a man with ED and no cardiac symptoms should be considered a cardiac (or vascular) patient until proven otherwise. For most men with no cardiac symptoms, we therefore have 2-3 years from ED onset to reduce the risk of a cardiovascular event. This article discusses the rationale for the link between ED and CAD, with reference to endothelial dysfunction, and the role of ED as an important means of identifying men at risk of vascular disease.
引用
收藏
页码:S9 / S14
页数:6
相关论文
共 50 条
  • [31] Cardiovascular disease, metabolic syndrome and erectile dysfunction
    Muller, Alexander
    Mulhall, John P.
    CURRENT OPINION IN UROLOGY, 2006, 16 (06) : 435 - 443
  • [32] Association of erectile dysfunction and subsequent cardiovascular disease
    Thompson, IM
    Probstfield, J
    Tangen, CM
    Goodman, P
    Moinpour, C
    Coltman, CA
    JOURNAL OF UROLOGY, 2006, 175 (04): : 429 - 429
  • [33] Interactions between erectile dysfunction, cardiovascular disease and cardiovascular drugs
    Dimitrios Terentes-Printzios
    Nikolaos Ioakeimidis
    Konstantinos Rokkas
    Charalambos Vlachopoulos
    Nature Reviews Cardiology, 2022, 19 : 59 - 74
  • [34] Interactions between erectile dysfunction, cardiovascular disease and cardiovascular drugs
    Terentes-Printzios, Dimitrios
    Ioakeimidis, Nikolaos
    Rokkas, Konstantinos
    Vlachopoulos, Charalambos
    NATURE REVIEWS CARDIOLOGY, 2022, 19 (01) : 59 - 74
  • [35] Erectile dysfunction in patients with cardiovascular disease: Consensus report
    Jackson, G
    Betteridge, J
    Hall, R
    Holdright, D
    Holmes, S
    Kirby, M
    Riley, A
    Sever, P
    HERZ KREISLAUF, 2000, 32 (01): : 6 - 8
  • [36] Erectile dysfunction: risk factor or manifestation of cardiovascular disease?
    Chien, C. V.
    Schwarz, E. R.
    INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2007, 19 (05) : 446 - 447
  • [37] Male erectile dysfunction and cardiovascular disease: Is there an intimate nexus?
    Chew, Kew-Kim
    Bremner, Alexandra
    Jamrozik, Konrad
    Earle, Carolyn
    Stuckey, Bronwyn
    JOURNAL OF SEXUAL MEDICINE, 2008, 5 (04): : 928 - 934
  • [38] Sex hormones, cardiovascular disease, and erectile dysfunction.
    McKinlay, JB
    Feldman, HA
    Durante, R
    Goldstein, I
    Longcope, C
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 1997, 145 (11) : 2 - 2
  • [39] Could erectile dysfunction be a marker of atherosclerotic cardiovascular disease?
    Sharvadze, G. G.
    Mamedov, M. N.
    Poddubskaya, E. A.
    Kurbatov, D. G.
    CARDIOVASCULAR THERAPY AND PREVENTION, 2010, 9 (07): : 79 - 84
  • [40] Should patients with erectile dysfunction be evaluated for cardiovascular disease?
    Ewane, Kenneth A.
    Lin, Hao-Cheng
    Wang, Run
    ASIAN JOURNAL OF ANDROLOGY, 2012, 14 (01) : 138 - 144